Click it and Unblock the Notifications
Just In
-
-
-
Don't Miss
-
Bade Miyan Chote Miyan Box Office Day 14: Akshay’s Film Struggles To Touch 60Cr; To Record Its Lowest Number -
Nitish Rana gets emotional while talking about his handicapped father driving Maruti 800 automatic -
Mumbai Opens BMC Headquarters For Exclusive Heritage Tour -
The Rise and Fall of the TVS Jive: India's Pioneering Clutchless Motorcycle -
TS Inter Results 2024 Toppers' List, Check Out the Districts That Top the List -
Summer Style: 6 Must-Try Colors To Stay Fashionably Cool Like B-Town Divas! -
PayU Gets RBI's In-principle Nod To Operate As Payment Aggregator -
Realme Narzo 70 5G, Narzo 70x 5G Launched in India: Check Price, Specs, Availability
Second vaccine against COVID-19 to be launched by Serum Institute in September
New Delhi, Mar 27: Adar Poonawalla, CEO of Serum Institute said that his company hopes to launch the second vaccine against COVID-19 by September this year.
Trials for Covovax made by Serum and US vaccine company Novavax are already underway in India.
Poonawalla said in a tweet that Covovax has been tested against the African and UK variants of COVID-19 and has an overall efficacy of 89 per cent.
In August 2020, American vaccine company Novavax, Inc had announced a licence agreement with SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate, in low and middle-income countries and India.
"Covovax trials finally begin in India; the vaccine is made through a partnership with @Novavax and @SerumInstIndia. It has been tested against African and UK variants of #COVID19 and has an overall efficacy of 89%. Hope to launch by September 2021!," Poonawalla said in a tweet.
